Eurax (Ranbaxy Laboratories Inc.)


Welcome to the PulseAid listing for the Eurax drug offered from Ranbaxy Laboratories Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ranbaxy Laboratories Inc.
NON-PROPRIETARY NAME: crotamiton
SUBSTANCE NAME: CROTAMITON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-12-15
END MARKETING DATE: 0000-00-00


Eurax HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEurax from Ranbaxy Laboratories Inc.
LABELER NAME: Ranbaxy Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/g)
START MARKETING DATE: 2008-12-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10631-091_f87f6e5f-30bc-4658-b7ed-7c2a823522a0
PRODUCT NDC: 10631-091
APPLICATION NUMBER: NDA006927

Other CROTAMITON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ranbaxy Laboratories Inc.Eurax